Add BrightSurf on Google Email

Science News for September 30, 2002


Fluke 87V Industrial Digital Multimeter

Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.

Cholesterol-lowering drugs safe and effective in children

A randomized trial of simvastatin in 173 children with heterozygous familial hypercholesterolemia found significant reductions in all cholesterol measures. The drug was well-tolerated and did not affect growth or pubertal development, making it a safe option for treating inherited high cholesterol in children.

SourceAmerican Heart Association·DateSep 30, 2002

Scientists discover genetic defect responsible for microcephaly

A study published in Nature Genetics reveals a gene mutation underlying Amish microcephaly, a birth defect marked by a small head and brain size. The researchers found that the defect disrupts mitochondrial function, leading to abnormal brain development.

SourceNIH/National Human Genome Research Institute·JournalNature Genetics·DateSep 30, 2002

Non-traditional tests may be dynamic duo in predicting heart problems

Researchers found that combining calcium scores and CRP levels can gauge the presence, amount, and stability of artery-clogging plaque. Elevated CRP levels were linked to increased risk of coronary events, while combined tests showed a six-fold difference in heart attack risk between high-risk and low-risk individuals.

SourceAmerican Heart Association·DateSep 30, 2002
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Elderly getting left out of critical cancer research

Leading oncology experts emphasize the need for additional research among elderly cancer patients with co-morbid conditions and those taking multiple medications. They advocate for equal access to treatment options as younger patients, highlighting a lack of focus on this critical patient population.

SourceShire Health New York·DateSep 30, 2002

Scientists discover role for c-myc gene in tumor angiogenesis

Researchers found that c-Myc is essential for tumor development by regulating blood vessel growth. The study suggests disrupting c-Myc may be a successful anti-angiogenic tool in cancer therapy, targeting tumors' vascular networks to slow growth.

SourceCold Spring Harbor Laboratory·JournalGenes & Development·DateSep 30, 2002

Molecular machine could develop drugs for bioweapons victims

Researchers at Los Alamos National Laboratory have developed a computer model of the E-coli ribosome, a cellular structure responsible for protein creation. This model has applications in developing new and powerful antibiotics against a range of pathogens, including those used in bioweapons agents.

SourceDOE/Los Alamos National Laboratory·JournalNature Structural & Molecular Biology·DateSep 30, 2002

Novel form of vitamin D shown to grow bone

Researchers at the University of Wisconsin-Madison have discovered a potent Vitamin D analog, known as 2MD, which significantly increases bone density in rats with osteoporosis. The compound has shown no apparent toxicity and may become an alternative to hormone replacement therapy.

SourceUniversity of Wisconsin-Madison·JournalProceedings of the National Academy of Sciences·DateSep 30, 2002
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

NIH funding establishes a chimpanzee sanctuary

The NIH has awarded a ten-year, $19 million contract to Chimp Haven to establish a chimpanzee sanctuary. The sanctuary will provide humane care for retired research chimpanzees and operate under standards established jointly by the NCRR advisory panel and the Chimp Haven Board of Directors.

SourceNIH/National Center for Advancing Translational Sciences (NCATS)·DateSep 30, 2002

Annals of Internal Medicine, tip sheet, October 1, 2002

Two studies found that patients with kidney disease are at increased risk of death after a heart attack, receiving less-aggressive treatment. Meanwhile, researchers report four cases of muscle damage caused by statins, highlighting the need for closer monitoring.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateSep 30, 2002

New technique widens the lens on cancer, could lead to new therapies

Researchers have developed a new technique to detect corrupted tumor suppressor genes affected by DNA methylation, which could lead to new therapies. The study found that DNA methylation primarily affects different genes than those damaged by deletion or mutation, suggesting a previously unrecognized source of therapeutic targets.

SourceUniversity of California - San Francisco·JournalNature Genetics·DateSep 30, 2002
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

Genetic findings in monkey herpes virus could aid research in human cancer

Researchers have identified three new genes in a rhesus monkey rhadinovirus with high structural similarity to those in human herpesvirus-8, paving the way for future studies using recombinant viruses. The goal is to develop targeted drug therapies against specific KSHV genes to prevent virus spread and cancer induction.

SourceUniversity of North Carolina Health Care·JournalJournal of Virology·DateSep 30, 2002